… that the inflammatory biomarker signatures may be particularly … that inflammatory biomarker
signatures may improve the … impairment due to Alzheimer's disease: recommendations from …

… cognition and FDG in Alzheimer's disease signature regions. … with high Alzheimer’s disease
pathology and APOE E4 carriage… of Alzheimer’s disease pathology and in APOE E4 carriers. …

… setting of Alzheimer's disease (AD). … pathology, these analyses will necessarily suffer from
the same uncertainties that are inherent in pathologic examination, namely that AD pathology …

… , including correlations between module eigengenes and cognitive/pathological traits, and
enrichment for gene expression signatures such as the DEGs and TCGs calculated above. To …

… Because this expression signature is evident in healthy brains, our analysis provides an …
risk of protein aggregation and a corresponding vulnerability to Alzheimer’s disease. …

… of tau and Aβ pathology in the absence of neuronal loss meant that ‘sick’ or dysfunctional
neurons would contribute substantially to the disease transcriptomic signature. A second …

… We observed an indirect effect of Aβ pathology on cognition through higher CSF GFAP
levels and … Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis. …

… The presence of such aberrant aggregate species generates a cascade of pathological
events, … meta-analyses carried out in this work for Alzheimer's disease and clinical depression …

… Although it is still unclear how the studies in mice with AD-like pathological features relate
to the human disease, our findings in plasma of patients with AD offer a framework to study the …

… on risk for Alzheimer’s disease (AD). We examined 829 participants (M age : 75.3 ± 6.9 years;
350 women and 479 men) from the Alzheimer’s Disease Neuroimaging Initiative database …